Live Status Check

NCT05655312 Recruiting Status

Real-time enrollment status for this melanoma clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 18, 2026 at 11:13 AM UTC

NCT05655312 Status Summary

NCT NumberNCT05655312
Recruiting StatusRecruiting
ConditionMelanoma
PhasePHASE1
Target Enrollment300 participants
Active Locations13 sites in the US
SponsorPerspective Therapeutics
Last Updated on CT.govJune 10, 2026 (Jun 10, 2026)

About NCT05655312 Enrollment Status

As of July 18, 2026: Clinical trial NCT05655312 is currently recruiting participants. This phase1 study for melanoma is actively seeking new participants at 13 locations across the United States. The study is sponsored by Perspective Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05655312

Is NCT05655312 still recruiting?

Yes, NCT05655312 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT05655312 recruiting?

This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05655312?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05655312 status last updated?

The official ClinicalTrials.gov record for NCT05655312 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial